Package Insert (PI) Table

Please note the following when using Package Inserts from this web site:

The drug labels and other drug-specific information on this website represent the most recent drug listing information that companies have provided to, or which is obtainable by, the Division of AIDS, NIAID, NIH (“DAIDS”), and are made available here in support of DAIDS-funded and/or -sponsored clinical trials, both domestic and international.   The drug labeling, and other information is as obtainable by DAIDS and its content has neither been altered nor verified by DAIDS; as such, this content may not be Section 508 compliant.  If in the use of adaptive equipment, you encounter problems accessing the content, DAIDS will assist access through equivalent facilitation.  Please e-mail DAIDSRSCwebsitesupport@tech-res.com for assistance.

Drugs

Drug Name Sort descending Drug Company PI Date Risk List Available?
Lamivudine (Epivir) GlaxoSmithKline September 2020 YES
Letermovir (Prevymis) Merck February 2021
Linezolid (Zyvox) Pfizer July 2018
Lopinavir/Ritonavir (Kaletra) AbbVie December 2019 YES
Peginterferon alfa 2b (Pegintron) Merck January 2019
Pitavastatin (Livalo) Kowa September 2020
Pravastatin Sandoz December 2006
Pyrazinamide Macleods Pharmaceuticals Limited May 2014
Raltegravir (Isentress) Merck July 2020 YES
Ribavirin Aurobindo Pharma Limited October 2018
Rifabutin Greenstone LLC April 2018
Rifampicin Macleods Pharmaceuticals Limited December 2018
Rifampin/Isoniazid/Pyrazinamide/Ethambutol (Rifafour e-276) Sanofi-Aventis April 2013
Rilpivirine (Edurant) Janssen January 2021 YES
Ritonavir (Norvir) Tablets/Oral Solution AbbVie December 2019
Semaglutide (Ozempic) Novo Nordisk April 2019
Tamoxifen Citrate Mylan Pharmaceuticals April 2013
Tenofovir Disoproxil Fumarate (Viread) Gilead Sciences April 2019 YES
Vorinostat (Zolinza) Merck January 2020
Zidovudine (Retrovir) Capsules, Syrup and IV Injection GlaxoSmithKline September 2018 YES